Jak2 is essential for signaling through a variety of cytokine receptors
- PMID: 9590173
- DOI: 10.1016/s0092-8674(00)81167-8
Jak2 is essential for signaling through a variety of cytokine receptors
Abstract
A variety of cytokines activate receptor-associated members of the Janus family of protein tyrosine kinases (Jaks). To assess the role of Jak2, we have derived Jak2-deficient mice. The mutation causes an embryonic lethality due to the absence of definitive erythropoiesis. Fetal liver myeloid progenitors, although present based on the expression of lineage specific markers, fail to respond to erythropoietin, thrombopoietin, interleukin-3 (IL-3), or granulocyte/macrophage colony-stimulating factor. In contrast, the response to granulocyte specific colony-stimulating factor is unaffected. Jak2-deficient fibroblasts failed to respond to interferon gamma (IFNgamma), although the responses to IFNalpha/beta and IL-6 were unaffected. Lastly, reconstitution experiments demonstrate that Jak2 is not required for the generation of lymphoid progenitors, their amplification, or functional differentiation. Therefore, Jak2 plays a critical, nonredundant role in the function of a specific group of cytokines receptors.
Similar articles
-
Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis.Cell. 1998 May 1;93(3):397-409. doi: 10.1016/s0092-8674(00)81168-x. Cell. 1998. PMID: 9590174
-
Erythropoiesis in the absence of janus-kinase 2: BCR-ABL induces red cell formation in JAK2(-/-) hematopoietic progenitors.Blood. 2001 Nov 15;98(10):2948-57. doi: 10.1182/blood.v98.10.2948. Blood. 2001. PMID: 11698276
-
The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases.Exp Hematol. 1995 Aug;23(9):1040-8. Exp Hematol. 1995. PMID: 7543416
-
Signaling by the cytokine receptor superfamily.Ann N Y Acad Sci. 1998 Dec 11;865:1-9. doi: 10.1111/j.1749-6632.1998.tb11157.x. Ann N Y Acad Sci. 1998. PMID: 9927991 Review.
-
Signaling via JAK tyrosine kinases: growth hormone receptor as a model system.Recent Prog Horm Res. 1998;53:61-82; discussion 82-3. Recent Prog Horm Res. 1998. PMID: 9769703 Review.
Cited by
-
Tyrosine kinase inhibitors induce mesenchymal stem cell-mediated resistance in BCR-ABL+ acute lymphoblastic leukemia.Blood. 2015 May 7;125(19):2968-73. doi: 10.1182/blood-2014-05-576421. Epub 2015 Feb 23. Blood. 2015. PMID: 25712988 Free PMC article.
-
Biology and significance of the JAK/STAT signalling pathways.Growth Factors. 2012 Apr;30(2):88-106. doi: 10.3109/08977194.2012.660936. Epub 2012 Feb 20. Growth Factors. 2012. PMID: 22339650 Free PMC article. Review.
-
Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model.Blood. 2006 Jun 1;107(11):4274-81. doi: 10.1182/blood-2005-12-4824. Epub 2006 Feb 14. Blood. 2006. PMID: 16478879 Free PMC article.
-
Identification of an acquired JAK2 mutation in polycythemia vera.J Biol Chem. 2005 Jun 17;280(24):22788-92. doi: 10.1074/jbc.C500138200. Epub 2005 Apr 29. J Biol Chem. 2005. PMID: 15863514 Free PMC article.
-
KDM3A histone demethylase functions as an essential factor for activation of JAK2-STAT3 signaling pathway.Proc Natl Acad Sci U S A. 2018 Nov 13;115(46):11766-11771. doi: 10.1073/pnas.1805662115. Epub 2018 Oct 30. Proc Natl Acad Sci U S A. 2018. PMID: 30377265 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous